₹ 471.04
NAV (Apr 11)
Sectoral / Thematic - Pharma And Healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).
The pharma benchmark index itself has been a material underperformer over an extended time frame.
Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.
Investment Duration5 years
7,32,612
Total Investment5,66,635
Wealth Gained12,99,247
Total Corpus Created (₹)
With CAGR of 22.396 % in 5 years₹ 471.0386
NAV (Apr 11)
Last 1Y | 9.2% |
Last 3Y | 16.6% |
Last 5Y | 22.4% |
Last 10Y | 12.6% |
Since Inception | 20.3% |
6 Month CAGR | -10.6% |
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Expense Ratio | 1.82 % |
Launched 20Y ago | 2004-06-05 |
AUM in Crores | 8081 |
ISIN | INF204K01968 |
Lock-in (days) | No Lock-in |
Benchmark | BSE Healthcare Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation | 15.6 |
Beta | 0.9 |
Sharpe Ratio | 0.7 |
of
for
with step up of
Asset | Returns | Total Corpus | Gains | CAGR |
---|---|---|---|---|
Nippon India Pharma Fund (G) | 12,99,247 | 5,66,635 | 22.4% | |
EPF | 9,00,761 | 1,68,149 | 8.50% | |
Property | 8,67,662 | 1,35,050 | 7.00% | |
PPF | 8,69,819 | 1,37,207 | 7.10% | |
Bank FD | 8,46,471 | 1,13,859 | 6.00% | |
Gold | 8,46,471 | 1,13,859 | 6.00% | |
Savings Bank | 8,25,950 | 93,338 | 5.00% |
Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.
Sun Pharmaceutical Industries Ltd.
13.85%Divi's Laboratories Ltd.
8.17%Lupin Ltd.
7.52%Cipla Ltd.
5.88%Dr. Reddy's Laboratories Ltd.
5.81%Healthcare
98.88%Fund Name | Fund Size | |
---|---|---|
₹ 23,379 cr | ||
₹ 64,962 cr | ||
₹ 27,730 cr | ||
₹ 16,217 cr | ||
₹ 49,131 cr |
Nippon India Mutual Fund
Fund Name | Scripbox Opinion | Till Date CAGR | |
---|---|---|---|
6.5% | 6.9% | ||
8.9% | 8.9% | ||
18.3% | 20.3% | ||
16% | 12.5% | ||
6.2% | 5.1% |
Investment Duration5 years
7,32,612
Total Investment5,66,635
Wealth Gained12,99,247
Total Corpus Created (₹)
With CAGR of 22.396 % in 5 yearsNippon India Pharma Fund (G) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 20.28% over 20 years. The fund has grown over a period of 20 years. The fund is managed by Nippon India Mutual Fund. The fund manager’s name is Sailesh Raj Bhan.
Nav of Nippon India Pharma Fund (G) as of 4/11/2025 is ₹471.04 with the total AUM as of 4/13/2025 is ₹8080.97. With Scripbox you can compare and check the latest nav for all mutual funds in India. Nippon India Pharma Fund (G) was launched on 2004-06-05. The category risk of the fund is Very High.
The minimum SIP amount for Nippon India Pharma Fund (G) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.
Nippon India Pharma Fund (G) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to BSE Healthcare Total Return Index.
Scripbox provides a compare mutual funds research tool to view a detailed comparison with Nippon India Pharma Fund (G).
What is Nippon India Pharma Fund (G)?
How to invest in Nippon India Pharma Fund (G)?
What is the minimum sip amount of Nippon India Pharma Fund (G)?
Is Nippon India Pharma Fund (G) good to invest in?
What is the expense ratio of the Nippon India Pharma Fund (G)?
What is the NAV of Nippon India Pharma Fund (G)?